United States Antiallergics Drugs Market was valued at USD 12.3 Billion in 2022 and is projected to reach USD 15.6 Billion by 2030, growing at a CAGR of 3.1% from 2024 to 2030.
The US Antiallergics Drugs Market is witnessing significant growth due to the rising prevalence of allergic conditions across the country. As individuals are increasingly affected by allergies, the demand for effective antiallergic treatments has surged. This demand spans across multiple industries, from healthcare providers to pharmaceutical manufacturers. With an increasing number of people suffering from seasonal allergies, food allergies, and skin conditions, the need for antiallergic drugs has become more critical than ever. The market is expected to continue expanding, driven by technological advancements in drug formulations and the growing awareness of available treatments.
The primary types of antiallergic drugs in the US market include antihistamines, corticosteroids, decongestants, and mast cell stabilizers. Antihistamines, which block the effects of histamine, a substance released during an allergic reaction, are the most widely used. Corticosteroids help reduce inflammation and are often prescribed for more severe allergic reactions. Decongestants are commonly used to treat nasal congestion, while mast cell stabilizers work to prevent allergic reactions before they start. Each of these drug types has its unique role in treating different allergy symptoms, and their demand is influenced by factors such as the type and severity of allergies among patients.
From an industry perspective, the demand for antiallergic drugs is multifaceted. Healthcare professionals, such as doctors and allergists, rely on these drugs to provide immediate relief to patients, while pharmaceutical companies are focused on developing innovative drug formulations to meet evolving patient needs. The increased investment in research and development is a key driver of market expansion, as companies work towards producing more effective and targeted treatments. Moreover, advancements in drug delivery systems, such as nasal sprays and oral tablets, have contributed to better patient compliance and overall treatment effectiveness.
Furthermore, the consumer-driven aspect of the US Antiallergics Drugs Market cannot be overlooked. With growing health awareness, consumers are actively seeking over-the-counter solutions for common allergic reactions. This shift has led to the widespread availability of antiallergic medications at pharmacies and retail outlets, making it easier for individuals to access necessary treatments quickly. In response, pharmaceutical companies are increasingly offering products that cater to this demand, providing a broad range of antiallergic drugs in various forms.
The continued growth of the US Antiallergics Drugs Market is supported by the increasing awareness of allergy-related health issues, a wider range of treatment options, and innovations in drug development. With the demand for these drugs on the rise, industries are continuously evolving to meet the needs of patients, making the market one of the most dynamic segments of the pharmaceutical industry.
Get an In-Depth Research Analysis of the US Antiallergics Drugs Market Size And Forecast [2025-2032]
Â
Akorn
Pfizer
GSK plc
Novartis AG
Mylan N.V.
Teva Pharmaceutical Industries
Sanofi
Boehringer Ingelheim International GmbH
AstraZeneca
Johnson & Johnson Private
Bayer AG
Merck & Co.
Prestige Consumer Healthcare
F. Hoffmann-La Roche
Bristol-Myers Squibb Company
Almirall
Zenomed Healthcare Private
Cadila Pharmaceuticals
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the US Antiallergics Drugs Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the US Antiallergics Drugs Market
First-Generation Antihistamines
Second-Generation Antihistamines
Leukotriene Receptor Antagonists
Intranasal Corticosteroids
Mast Cell Stabilizers
Oral
Intranasal
Topical
Injectable
Seasonal Allergic Rhinitis
Perennial Allergic Rhinitis
Atopic Dermatitis
Allergic Conjunctivitis
Anaphylaxis
Pediatric
Adult
Geriatric
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Antiallergics Drugs Market Research Analysis
1. Introduction of the US Antiallergics Drugs Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. US Antiallergics Drugs Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. US Antiallergics Drugs Market, By Type
6. US Antiallergics Drugs Market, By Application
7. US Antiallergics Drugs Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. US Antiallergics Drugs Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading US Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/